PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Shoulder Bursitis 8 Disease Disease Arthritis 128,324 1 0.00 -0.94 0.12 0.58
Shoulder Bursitis 8 Disease Disease Headache 50,687 1 0.00 -0.94 0.12 0.60
Shoulder Bursitis 8 Disease Disease Rheumatoid Arthritis 78,952 1 0.00 -0.94 0.12 0.59
Shoulder Bursitis 8 Disease Disease Bursitis 2,133 8 0.06 -0.33 1.00 0.75
Shoulder Bursitis 8 Disease Disease Pain 409,851 2 0.00 -0.87 0.25 0.57
Shoulder Bursitis 8 Disease Disease Inflammation 252,734 1 0.00 -0.94 0.12 0.57
Carcinoma Basal Cell 8 Disease Disease Carcinoma 433,099 8 0.00 -0.33 1.00 0.60
Carcinoma Basal Cell 8 Disease Disease Cancer 1,053,491 5 0.00 -0.61 0.62 0.57
Carcinoma Basal Cell 8 Disease Disease Skin Cancer 11,561 4 0.01 -0.71 0.50 0.67
Carcinoma Basal Cell 8 Disease Disease Basal Cell Carcinoma 7,953 6 0.02 -0.50 0.75 0.69
Carcinoma Basal Cell 8 Disease Disease Organ Transplantation 11,384 1 0.00 -0.94 0.12 0.64
Carcinoma Basal Cell 8 Disease Disease Arthritis 128,324 1 0.00 -0.94 0.12 0.58
Carcinoma Basal Cell 8 Disease Disease Rheumatoid Arthritis 78,952 1 0.00 -0.94 0.12 0.59
Carcinoma Basal Cell 8 Disease Disease Psoriasis 26,882 1 0.00 -0.94 0.12 0.62
Deficiency Vitamin D 8 Disease Disease Osteoporosis 46,215 1 0.00 -0.94 0.12 0.60
Deficiency Vitamin D 8 Disease Disease Arthritis 128,324 1 0.00 -0.94 0.12 0.58
Deficiency Vitamin D 8 Disease Disease Cholesterol 182,390 1 0.00 -0.94 0.12 0.57
Deficiency Vitamin D 8 Disease Disease Deficiency Vitamin 24 8 0.58 -0.27 1.00 0.94
Deficiency Vitamin D 8 Disease Disease Asthma 109,610 2 0.00 -0.87 0.25 0.60
Deficiency Vitamin D 8 Disease Disease Muscle Weakness 9,178 1 0.00 -0.94 0.12 0.64
Deficiency Vitamin D 8 Disease Disease Inflammation 252,734 1 0.00 -0.94 0.12 0.57
Atarax (Hydroxyzine Hydrochloride)- FDA 8 Drug Disease Allergies 10,264 1 0.00 -0.94 0.12 0.64
Atarax (Hydroxyzine Hydrochloride)- FDA 8 Drug Disease Anxiety 113,510 3 0.00 -0.79 0.38 0.61
Atarax (Hydroxyzine Hydrochloride)- FDA 8 Drug Disease Allergic Rhinitis 12,280 1 0.00 -0.94 0.12 0.63
Atarax (Hydroxyzine Hydrochloride)- FDA 8 Drug Disease Asthma 109,610 1 0.00 -0.94 0.12 0.58
Atarax (Hydroxyzine Hydrochloride)- FDA 8 Drug Drug Adrenalin (Epinephrine)- FDA 42 1 0.05 -0.92 0.12 0.81
Atarax (Hydroxyzine Hydrochloride)- FDA 8 Drug Drug Abecarnil 121 2 0.06 -0.86 0.25 0.80
Atarax (Hydroxyzine Hydrochloride)- FDA 8 Drug Disease Anxiety Disorder 8,985 3 0.01 -0.79 0.38 0.67
Atarax (Hydroxyzine Hydrochloride)- FDA 8 Drug Drug Ambien (Zolpidem Tartrate)- FDA 24 1 0.07 -0.92 0.12 0.84
Atarax (Hydroxyzine Hydrochloride)- FDA 8 Drug Disease Urticaria 10,717 1 0.00 -0.94 0.12 0.64
Alprazolam (Xanax)- FDA 8 Drug Drug Drospirenone 514 1 0.02 -0.93 0.12 0.72
Alprazolam (Xanax)- FDA 8 Drug Disease Seizures 66,465 1 0.00 -0.94 0.12 0.60
Dromostanolone 8 Drug Disease Breast Cancer 173,695 3 0.00 -0.79 0.38 0.60
ADRBK2 8 Target Disease Carcinoma 433,099 1 0.00 -0.94 0.12 0.56
ADRBK2 8 Target Disease Cancer 1,053,491 2 0.00 -0.87 0.25 0.55
ADRBK2 8 Target Disease Ovarian Cancer 33,996 1 0.00 -0.94 0.12 0.61
ADRBK2 8 Target Disease Schizophrenia 77,034 1 0.00 -0.94 0.12 0.59
ADRBK2 8 Target Disease Breast Cancer 173,695 1 0.00 -0.94 0.12 0.58
ADRBK2 8 Target Target Beta-Adrenergic Receptor Kinase 2 15 4 0.37 -0.61 0.50 0.93
CD62L/L-Selectin 8 Target Disease Carcinoma 433,099 1 0.00 -0.94 0.12 0.56
CD62L/L-Selectin 8 Target Disease Cancer 1,053,491 2 0.00 -0.87 0.25 0.55
CD62L/L-Selectin 8 Target Disease Inflammatory Bowel Disease 24,375 1 0.00 -0.94 0.12 0.62
CD62L/L-Selectin 8 Target Disease Infection 766,637 1 0.00 -0.94 0.12 0.55
CD62L/L-Selectin 8 Target Disease Shock 134,031 1 0.00 -0.94 0.12 0.58
CD62L/L-Selectin 8 Target Disease Arthritis 128,324 1 0.00 -0.94 0.12 0.58
CD62L/L-Selectin 8 Target Target Platelet Activating Factor 9,915 1 0.00 -0.94 0.12 0.64
CD62L/L-Selectin 8 Target Disease Bacterial Infections 14,248 1 0.00 -0.94 0.12 0.63
CD62L/L-Selectin 8 Target Disease Lung Cancer 91,416 1 0.00 -0.94 0.12 0.59
CD62L/L-Selectin 8 Target Disease Inflammation 252,734 1 0.00 -0.94 0.12 0.57
Glutathione S-Transferase Mu 2 8 Target Disease Inflammation 252,734 2 0.00 -0.87 0.25 0.58
Glutathione S-Transferase Mu 2 8 Target Disease Glioblastoma 17,933 1 0.00 -0.94 0.12 0.63
Prostaglandin Reductase 1 8 Target Disease Inflammation 252,734 2 0.00 -0.87 0.25 0.58
Prostaglandin Reductase 1 8 Target Disease Heart Disease 118,291 1 0.00 -0.94 0.12 0.58
Doxorubicin-Formaldehyde Conjugate 9 Drug Disease Cancer 1,053,491 9 0.00 -0.32 1.00 0.58
Doxorubicin-Formaldehyde Conjugate 9 Drug Disease Prostate Cancer 71,064 3 0.00 -0.82 0.33 0.62
Doxorubicin-Formaldehyde Conjugate 9 Drug Drug Doxoform 9 4 0.44 -0.56 0.44 0.95
Doxorubicin-Formaldehyde Conjugate 9 Drug Disease Leukemia 162,805 1 0.00 -0.94 0.11 0.57
Doxorubicin-Formaldehyde Conjugate 9 Drug Disease Breast Cancer 173,695 2 0.00 -0.88 0.22 0.59
Doxorubicin-Formaldehyde Conjugate 9 Drug Drug Doxazolidine 9 2 0.22 -0.78 0.22 0.92
Doxorubicin-Formaldehyde Conjugate 9 Drug Drug Doxorubicin 28,033 9 0.02 -0.32 1.00 0.67
Aprotinin (Trasylol)- FDA 9 Drug Target Elastase 13,875 1 0.00 -0.94 0.11 0.63
Doxoform 9 Drug Disease Breast Cancer 173,695 2 0.00 -0.88 0.22 0.59
Doxoform 9 Drug Drug Doxazolidine 9 2 0.22 -0.78 0.22 0.92
Doxoform 9 Drug Drug Doxorubicin 28,033 9 0.02 -0.32 1.00 0.67
Doxazolidine 9 Drug Drug Doxorubicin 28,033 7 0.01 -0.47 0.78 0.66
Doxazolidine 9 Drug Disease Glioblastoma 17,933 1 0.00 -0.94 0.11 0.62
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Overactive Bladder 3,492 1 0.01 -0.94 0.11 0.67
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Infection 766,637 1 0.00 -0.94 0.11 0.54
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Schizophrenia 77,034 1 0.00 -0.94 0.11 0.59
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Epilepsy 71,172 3 0.00 -0.82 0.33 0.62
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Cholesterol 182,390 1 0.00 -0.94 0.11 0.57
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Diabetic Retinopathy 14,494 1 0.00 -0.94 0.11 0.63
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Seizures 66,465 1 0.00 -0.94 0.11 0.59
CINC-2- alpha 9 Target Disease Inflammation 252,734 4 0.00 -0.75 0.44 0.59
Carbonic Anhydrase 4 9 Target Target ADRP 537 1 0.01 -0.94 0.11 0.72
Carbonic Anhydrase 4 9 Target Disease Inflammation 252,734 1 0.00 -0.94 0.11 0.57
CXCL4/PF4 9 Target Target Cytokeratin 18 1,108 1 0.01 -0.94 0.11 0.70
CD254 9 Target Target CCL21 808 1 0.01 -0.94 0.11 0.71
Lupus Erythematosus Discoid 10 Disease Disease Ringworm 880 1 0.01 -0.95 0.10 0.70
Lupus Erythematosus Discoid 10 Disease Disease Psoriasis 26,882 1 0.00 -0.95 0.10 0.61
Lupus Erythematosus Discoid 10 Disease Disease Inflammation 252,734 1 0.00 -0.95 0.10 0.56
Lupus Erythematosus Discoid 10 Disease Disease Urticaria 10,717 1 0.00 -0.95 0.10 0.63
Sclerosis Multiple 10 Disease Disease Arthritis 128,324 2 0.00 -0.89 0.20 0.59
Sclerosis Multiple 10 Disease Disease Rheumatoid Arthritis 78,952 2 0.00 -0.89 0.20 0.60
Sclerosis Multiple 10 Disease Disease Amyotrophic Lateral Sclerosis 14,006 2 0.01 -0.89 0.20 0.65
Sclerosis Multiple 10 Disease Disease Inflammation 252,734 1 0.00 -0.95 0.10 0.56
Asparaginase (Elspar)- FDA 10 Drug Disease Burns 26,206 1 0.00 -0.95 0.10 0.61
Asparaginase (Elspar)- FDA 10 Drug Disease Cancer 1,053,491 2 0.00 -0.89 0.20 0.55
Asparaginase (Elspar)- FDA 10 Drug Disease Hyperglycemia 28,168 1 0.00 -0.95 0.10 0.61
Asparaginase (Elspar)- FDA 10 Drug Disease Hyperbilirubinemia 5,757 1 0.00 -0.95 0.10 0.65
Asparaginase (Elspar)- FDA 10 Drug Disease Shock 134,031 1 0.00 -0.95 0.10 0.58
Asparaginase (Elspar)- FDA 10 Drug Target Adenosine Deaminase 6,613 1 0.00 -0.95 0.10 0.65
Asparaginase (Elspar)- FDA 10 Drug Disease Leukemia 162,805 8 0.01 -0.45 0.80 0.62
Anakinra (Kineret)- FDA 10 Drug Disease Sedimentation Rate 11,455 1 0.00 -0.95 0.10 0.63
Anakinra (Kineret)- FDA 10 Drug Disease Obesity 138,233 1 0.00 -0.95 0.10 0.58
Anakinra (Kineret)- FDA 10 Drug Disease Cancer 1,053,491 1 0.00 -0.95 0.10 0.54
Anakinra (Kineret)- FDA 10 Drug Disease Tuberculosis 146,217 2 0.00 -0.89 0.20 0.59
Anakinra (Kineret)- FDA 10 Drug Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
Anakinra (Kineret)- FDA 10 Drug Drug Adalimumab (Humira)- FDA 62 1 0.04 -0.94 0.10 0.80
Anakinra (Kineret)- FDA 10 Drug Disease Arthritis 128,324 8 0.01 -0.45 0.80 0.62